~~<i id='C05866824F'><strike id='C05866824F'><tt id='C05866824F'><pre id='C05866824F'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

comprehensive

author：explore 2025-09-14 18:32:59 - browse：511

Senate health committee Chair Bernie Sanders — Sen. Berne Sanders (I-Vt.) Kevin Dietsch/Getty Images

WASHINGTON — Sen. Bernie Sanders (I-Vt.) has a new corporate target: the food industry.

Sanders held a hearing today on diabetes that implicated both the food and drug industries in what the American Diabetes Association estimates is a $413 billion annual cost to the health care system. That’s up 27% over the past six years, he said, and he warned that new weight loss drugs could send health care spending to the stratosphere.

But the food industry received more attention, especially from Sanders, than the drugmakers and drug middlemen.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： As demand for Covid shots wanes, Moderna seeks its next success
Next article： A Q&A with the global head of Boehringer Ingelheim's innovation unit

entertainment

knowledge

hotspot

explore

hotspot

focus

AdobeTodayistheinauguralpublishingdayforAdam’sBiotechScorecard—asubscriber-onlynewsletterofferingsen

WSS

Histogen: Failed biotech offers rare public look inside

When women are denied an abortion, their children fare worse than peers

Scientists boost immune system in aging mice by making it youthful

Why age limits for politicians are a terrible idea

Scientists boost immune system in aging mice by making it youthful

Vertex Pharmaceuticals may move headquarters in Boston

focus

comprehensive

entertainment

United colonoscopy coverage change 'may cost lives,' doctors say

Why the world’s most expensive drug might be worth the price

Malaria cases in Florida and Texas: Here’s what you need to know

Phenylephrine and the overlooked value of the placebo effect

At least 13 dead in Texas as scorching temps continue

Histogen: Failed biotech offers rare public look inside

Medical records are filled with copy

Primary care physicians play key roles in Alzheimer's management

Alkermes shareholders re

3 questions for the future of Biden's cancer moonshot

knowledge

Colorectal cancer study finds potential in overlooked immune cell

Study says nonprofit hospitals fall short in charity care spending

Adam's Biotech Scorecard: A closer look at Viking Therapeutics, PDS Biotech

Scientists boost immune system in aging mice by making it youthful

Merck drug for rare lung condition set for approval in U.S.

Readout Newsletter: WuXi and Congress, Boundless Bio, etc.

hotspot

explore

hotspot

focus